
<DOC>
<DOCNO>
WSJ900815-0088
</DOCNO>
<DOCID>
900815-0088.
</DOCID>
<HL>
   Liposome Technology Inc.
</HL>
<DATE>
08/15/90
</DATE>
<SO>
WALL STREET JOURNAL (J), NO PAGE CITATION
</SO>
<CO>
   LTIZ
</CO>
<IN>
TENDER OFFERS, MERGERS, ACQUISITIONS (TNM)
</IN>
<LP>
   MENLO PARK, Calif. -- New York investor David Blech said
in a filing with the Securities and Exchange Commission that
he increased his stake in Liposome Technology Inc. to 35.3%
of the common shares outstanding.
   Mr. Blech said he holds 3,573,680 shares, including
123,500 shares purchased Aug. 1 at prices of $3.06 to $3.50 a
share. No reason was given for the boost.
</LP>
<TEXT>
   A Liposome spokesman said Mr. Blech already is the
company's largest shareholder, but was unable to confirm the
recent additions to his stake.
</TEXT>
</DOC>